These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2437245

  • 1. Human monoclonal antibodies neutralizing human cytomegalovirus.
    Masuho Y, Matsumoto Y, Sugano T, Fujinaga S, Minamishima Y.
    J Gen Virol; 1987 May; 68 ( Pt 5)():1457-61. PubMed ID: 2437245
    [Abstract] [Full Text] [Related]

  • 2. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.
    Ohlin M, Sundqvist VA, Mach M, Wahren B, Borrebaeck CA.
    J Virol; 1993 Feb; 67(2):703-10. PubMed ID: 7678304
    [Abstract] [Full Text] [Related]

  • 3. A human cytomegalovirus-neutralizing monoclonal antibody recognizes a normal cell protein.
    Michelson S, Tardy-Panit M, Colimon R, Landini MP.
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():673-84. PubMed ID: 2471796
    [Abstract] [Full Text] [Related]

  • 4. Development of human monoclonal antibodies against human cytomegalovirus.
    Kanoh Y, Yunoki M, Taniguchi T, Suzuki Y, Ideno S, Morita E, Hirama M, Yokoyama K, Yamanishi K.
    Hybridoma; 1992 Oct; 11(5):569-79. PubMed ID: 1281135
    [Abstract] [Full Text] [Related]

  • 5. Preparation of human monoclonal antibodies against a cytomegalovirus glycoprotein complex of 130 and 55 kDa.
    Tomiyama T, Matsumoto Y, Sugano T, Fujinaga S, Masuho Y.
    J Immunol Methods; 1990 Aug 07; 131(2):249-55. PubMed ID: 1697318
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C, Norrby E, Mufson MA.
    J Gen Virol; 1987 Dec 07; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [Abstract] [Full Text] [Related]

  • 7. Syngeneic monoclonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope.
    Keay S, Rasmussen L, Merigan TC.
    J Immunol; 1988 Feb 01; 140(3):944-8. PubMed ID: 2448380
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monoclonal IgM antibodies from cytomegalovirus-infected mice recognize the GlcNAc-containing receptor determinant of murine CMV as well as neutralizing anti-CMV IgG antibodies.
    Ravindranath RM, Graves MC.
    Virology; 1992 May 01; 188(1):143-51. PubMed ID: 1373551
    [Abstract] [Full Text] [Related]

  • 12. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
    Stave JW, Card JL, Morgan DO.
    J Gen Virol; 1986 Oct 01; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies.
    Czerny CP, Mahnel H.
    J Gen Virol; 1990 Oct 01; 71 ( Pt 10)():2341-52. PubMed ID: 1700065
    [Abstract] [Full Text] [Related]

  • 15. Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus.
    Kim KS, Sapienza VJ, Chen CM, Wisniewski K.
    J Clin Microbiol; 1983 Aug 01; 18(2):331-43. PubMed ID: 6194174
    [Abstract] [Full Text] [Related]

  • 16. Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.
    Morita Y, Taniguchi K, Urasawa T, Urasawa S.
    J Gen Virol; 1988 Feb 01; 69 ( Pt 2)():451-8. PubMed ID: 2448418
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants.
    Pereira L, Hoffman M, Gallo D, Cremer N.
    Infect Immun; 1982 Jun 01; 36(3):924-32. PubMed ID: 6178693
    [Abstract] [Full Text] [Related]

  • 18. Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies.
    Farrell HE, Shellam GR.
    J Gen Virol; 1991 Jan 01; 72 ( Pt 1)():149-56. PubMed ID: 1846643
    [Abstract] [Full Text] [Related]

  • 19. Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus.
    Rasmussen L, Mullenax J, Nelson R, Merigan TC.
    J Virol; 1985 Aug 01; 55(2):274-80. PubMed ID: 2410626
    [Abstract] [Full Text] [Related]

  • 20. Properties of monoclonal antibodies against Berne virus (Toroviridae).
    Kaeffer B, van Kooten P, Ederveen J, van Eden W, Horzinek MC.
    Am J Vet Res; 1989 Jul 01; 50(7):1131-7. PubMed ID: 2476050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.